Charles River Laboratories Common Stock Net 2010-2025 | CRL

Charles River Laboratories common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  • Charles River Laboratories common stock net for the quarter ending March 31, 2025 was $0.001B, a 0.58% decline year-over-year.
  • Charles River Laboratories common stock net for 2024 was $0.001B, a 0.39% decline from 2023.
  • Charles River Laboratories common stock net for 2023 was $0.001B, a 0.79% increase from 2022.
  • Charles River Laboratories common stock net for 2022 was $0.001B, a 0.79% increase from 2021.
Charles River Laboratories Annual Common Stock Net
(Millions of US $)
2024 $1
2023 $1
2022 $1
2021 $1
2020 $0
2019 $0
2018 $0
2017 $1
2016 $1
2015 $1
2014 $1
2013 $1
2012 $1
2011 $1
2010 $1
2009 $1
Charles River Laboratories Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $1
2024-12-31 $1
2024-09-30 $1
2024-06-30 $1
2024-03-31 $1
2023-12-31 $1
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $1
2022-06-30 $1
2022-03-31 $1
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $1
2010-06-30 $1
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Services $8.226B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.523B 26.43
CVS Health (CVS) United States $80.437B 10.00
Elevance Health (ELV) United States $62.242B 8.37
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $24.380B 25.90
Labcorp Holdings (LH) United States $21.895B 17.40
Natera (NTRA) United States $19.133B 0.00
BioMerieux (BMXMF) France $17.067B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.105B 0.00
ICON (ICLR) Ireland $13.404B 12.90
CochLear (CHEOY) Australia $13.242B 0.00
Solventum (SOLV) United States $12.531B 13.27
Medpace Holdings (MEDP) United States $12.257B 32.44
Viatris (VTRS) United States $10.540B 3.62
Revvity (RVTY) United States $10.453B 18.14
Sonic Healthcare (SKHHY) Australia $8.877B 0.00
Avantor (AVTR) United States $7.935B 11.64
HealthEquity (HQY) United States $7.870B 34.47
Caris Life Sciences,�Inc (CAI) United States $7.708B 0.00
Bausch + Lomb (BLCO) Canada $5.109B 34.38
Amplifon S.p.A (AMFPF) Italy $3.890B 21.30
BrightSpring Health Services (BTSG) United States $3.516B 26.82
Sotera Health (SHC) United States $3.176B 18.05
GeneDx Holdings (WGS) United States $3.043B 70.16
Surgery Partners (SGRY) United States $2.837B 35.71
Alignment Healthcare (ALHC) United States $2.656B 0.00
Concentras Parent (CON) United States $2.540B 14.68
Organon (OGN) United States $2.184B 2.38
Progyny (PGNY) United States $1.990B 43.81
Premier (PINC) United States $1.788B 13.57
PACS (PACS) United States $1.740B 0.00
GoodRx Holdings (GDRX) United States $1.568B 31.36
Ardent Health (ARDT) United States $1.523B 5.88
Establishment Labs Holdings (ESTA) $1.273B 0.00
Teladoc Health (TDOC) United States $1.230B 0.00
Pediatrix Medical (MD) United States $1.110B 7.51
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.831B 285.00
CareDx (CDNA) United States $0.715B 11.17
AMN Healthcare Services Inc (AMN) United States $0.670B 6.27
Performant Healthcare (PHLT) United States $0.597B 0.00
Embecta (EMBC) United States $0.580B 3.91
LifeMD (LFMD) United States $0.538B 0.00
Nutex Health (NUTX) United States $0.506B 7.67
So-Young (SY) China $0.499B 0.00
Auna S.A (AUNA) Luxembourg $0.466B 10.50
InnovAge Holding (INNV) United States $0.466B 0.00
Sonida Senior Living (SNDA) United States $0.457B 0.00
SBC Medicals (SBC) United States $0.453B 0.00
Omada Health (OMDA) $0.446B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.430B 0.00
Agilon Health (AGL) United States $0.365B 0.00
Oncology Institute (TOI) United States $0.353B 0.00
Enhabit (EHAB) United States $0.339B 27.88
Beauty Health (SKIN) United States $0.208B 0.00
DocGo (DCGO) United States $0.143B 23.33
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
Sera Prognostics (SERA) United States $0.092B 0.00
Biodesix (BDSX) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
KindlyMD (NAKA) United States $0.053B 0.00
IceCure Medical (ICCM) Israel $0.052B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
ModivCare (MODV) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.014B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
Pheton Holdings (PTHL) China $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00